AU3192700A - Medicinal compositions - Google Patents
Medicinal compositionsInfo
- Publication number
- AU3192700A AU3192700A AU31927/00A AU3192700A AU3192700A AU 3192700 A AU3192700 A AU 3192700A AU 31927/00 A AU31927/00 A AU 31927/00A AU 3192700 A AU3192700 A AU 3192700A AU 3192700 A AU3192700 A AU 3192700A
- Authority
- AU
- Australia
- Prior art keywords
- medicinal compositions
- medicinal
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Glanulating (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11/72145 | 1999-03-17 | ||
JP7214599 | 1999-03-17 | ||
PCT/JP2000/001606 WO2000054811A1 (fr) | 1999-03-17 | 2000-03-16 | Compositions medicamenteuses |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3192700A true AU3192700A (en) | 2000-10-04 |
Family
ID=13480822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU31927/00A Abandoned AU3192700A (en) | 1999-03-17 | 2000-03-16 | Medicinal compositions |
Country Status (12)
Country | Link |
---|---|
US (3) | US20050152975A1 (ja) |
EP (2) | EP2275141A1 (ja) |
JP (2) | JP4694669B2 (ja) |
KR (1) | KR100768034B1 (ja) |
CN (1) | CN1343128B (ja) |
AU (1) | AU3192700A (ja) |
CA (1) | CA2367373C (ja) |
HK (1) | HK1044476B (ja) |
NO (1) | NO20014490L (ja) |
RU (1) | RU2270695C2 (ja) |
TW (1) | TWI251495B (ja) |
WO (1) | WO2000054811A1 (ja) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4570725B2 (ja) * | 2000-04-05 | 2010-10-27 | 大塚製薬株式会社 | 医薬製剤用組成物 |
JPWO2002024167A1 (ja) * | 2000-09-19 | 2004-01-29 | 第一製薬株式会社 | 医薬組成物 |
MXPA03003146A (es) * | 2000-10-13 | 2004-12-06 | Advancis Pharmaceuticals | Derivados de eritromicina de liberacion prolongada. |
JP2002138034A (ja) * | 2000-10-27 | 2002-05-14 | Kyoto Pharmaceutical Industries Ltd | 苦味マスキングチュアブル錠およびその製造方法 |
BR0207930A (pt) | 2001-03-05 | 2004-03-02 | Ortho Mcneil Pharm Inc | Composições farmacêuticas lìquidas com sabor mascarado |
FR2848855B1 (fr) * | 2002-12-23 | 2005-02-11 | Aventis Pharma Sa | Compositions pour administration orale de principes actifs necessitant un masquage du gout |
US20040146553A1 (en) | 2002-12-23 | 2004-07-29 | Aventis Pharma S.A. | Compositions for oral administration of active principles requiring masking of taste |
DE10305984A1 (de) * | 2003-02-13 | 2004-09-02 | Helm Ag | Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen |
CN1744881A (zh) * | 2003-04-02 | 2006-03-08 | 普利瓦研究与发展有限公司 | 苦味减轻了的药物组合物 |
CN100548381C (zh) * | 2003-09-12 | 2009-10-14 | 株式会社龙角散 | 能掩盖苦味的粒状凝胶饮料 |
JP4385802B2 (ja) * | 2004-03-16 | 2009-12-16 | 味の素株式会社 | 粉末透析剤の製造方法 |
US20070020330A1 (en) | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
MX2007006233A (es) | 2004-11-24 | 2007-11-23 | Medpointe Healthcare Inc | Composiciones que comprenden azelastina y metodos de uso de la misma. |
US9101160B2 (en) | 2005-11-23 | 2015-08-11 | The Coca-Cola Company | Condiments with high-potency sweetener |
RS53624B1 (en) | 2006-03-16 | 2015-04-30 | Euro-Celtique S.A. | PHARMACEUTICAL SFEROIDS |
WO2008001201A2 (en) * | 2006-06-28 | 2008-01-03 | Wockhardt Ltd | Pharmaceutical compositions of clopidogrel |
EP1900358A1 (en) * | 2006-09-16 | 2008-03-19 | Cimex Pharma AG | Pharmaceutical formulations comprising clopidogrel |
US8017168B2 (en) | 2006-11-02 | 2011-09-13 | The Coca-Cola Company | High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith |
JP5318400B2 (ja) * | 2006-11-20 | 2013-10-16 | 第一三共株式会社 | レボフロキサシン含有錠剤 |
US20090028935A1 (en) * | 2006-12-01 | 2009-01-29 | Kristin Arnold | Carvedilol forms, compositions, and methods of preparation thereof |
WO2008070072A2 (en) * | 2006-12-01 | 2008-06-12 | Mutual Pharmaceutical Company, Inc. | Carvedilol forms, compositions, and methods of preparation thereof |
FR2913884A1 (fr) * | 2007-03-21 | 2008-09-26 | Oralance Pharma Sa | Systeme galenique hydrophobe non ionisable |
EP2095815B1 (en) * | 2008-02-26 | 2011-10-26 | Laboratorios Lesvi, S.L. | Pharmaceutical formulations containing clopidogrel |
EP2198859A1 (en) * | 2008-12-17 | 2010-06-23 | Losan Pharma GmbH | Melt-coated pharmaceutical composition with fast release |
US20110021591A1 (en) | 2009-07-21 | 2011-01-27 | Gordon Douglas J | Phenylbutazone carrier formulation showing increased bioactivity in animals |
JP2013032289A (ja) * | 2009-10-28 | 2013-02-14 | Daiichi Sankyo Co Ltd | ワックス安定製剤 |
JP5725884B2 (ja) * | 2011-01-27 | 2015-05-27 | 理研ビタミン株式会社 | 経口用製剤 |
US9119793B1 (en) | 2011-06-28 | 2015-09-01 | Medicis Pharmaceutical Corporation | Gastroretentive dosage forms for doxycycline |
CN103181885A (zh) * | 2011-12-30 | 2013-07-03 | 北京韩美药品有限公司 | 氯吡格雷的固体制剂及制备方法 |
US10842802B2 (en) | 2013-03-15 | 2020-11-24 | Medicis Pharmaceutical Corporation | Controlled release pharmaceutical dosage forms |
HUP1400294A2 (hu) | 2014-06-13 | 2015-12-28 | Skillpharm Kft | Clopidogrel új alkalmazása |
CN107335058B (zh) * | 2017-07-31 | 2021-01-08 | 暨南大学 | 一种2,6-二取代吡啶-4-硫代甲酰胺的新用途 |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2215948B1 (ja) | 1973-02-01 | 1976-05-14 | Centre Etd Ind Pharma | |
JPS53141286A (en) | 1977-05-16 | 1978-12-08 | Kyorin Seiyaku Kk | Novel substituted quinolinecarboxylic acid |
JPS5531042A (en) | 1978-08-25 | 1980-03-05 | Dainippon Pharmaceut Co Ltd | 1,8-naphthylidine derivative and its salt |
JPS5746986A (en) | 1980-09-02 | 1982-03-17 | Dai Ichi Seiyaku Co Ltd | Pyrido(1,2,3-de)(1,4)benzoxazine derivative |
DE3033157A1 (de) | 1980-09-03 | 1982-04-01 | Bayer Ag, 5090 Leverkusen | 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
FR2508459A1 (fr) | 1981-06-30 | 1982-12-31 | Sanofi Sa | Procede de preparation de derives de la tetrahydro-5,6,7,7a 4h thieno (3,2-c) pyridinone-2 |
FR2530247B1 (fr) | 1982-07-13 | 1986-05-16 | Sanofi Sa | Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique |
FR2548664B1 (fr) | 1983-07-06 | 1986-03-21 | Provesan Sa | Derives 7-(pyrrol-l-yl) des acides l-ethyl-1,4-dihydro-4-oxoquinoleine-3-carboxyliques et l-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridine)-3-carboxyliques substitues, leur preparation et leur application en tant que medicaments |
JPS6064979A (ja) | 1983-09-19 | 1985-04-13 | Hokuriku Seiyaku Co Ltd | 7−ピペラジン置換−6−フルオロ−4−オキソ−1,4−ジヒドロキノリン−3−カルボン酸誘導体 |
JPS60228479A (ja) | 1984-04-26 | 1985-11-13 | Toyama Chem Co Ltd | 1,4−ジヒドロ−4−オキソナフチリジン誘導体およびその塩 |
ZA864518B (en) | 1985-06-20 | 1987-03-25 | Daiichi Seiyaku Co | Optically active pyridobenzoxazine derivatives and intermediates thereof |
GB8518301D0 (en) * | 1985-07-19 | 1985-08-29 | Fujisawa Pharmaceutical Co | Hydrodynamically explosive systems |
AU594983B2 (en) | 1985-10-29 | 1990-03-22 | Dainippon Pharmaceutical Co. Ltd. | Novel quinoline derivatives and processes for preparation thereof |
JPH089597B2 (ja) | 1986-01-21 | 1996-01-31 | 杏林製薬株式会社 | 選択毒性に優れた8‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法 |
US5563138A (en) | 1987-04-16 | 1996-10-08 | Otsuka Pharmaceutical Company, Limited | Benzoheterocyclic compounds |
NL193682C (nl) * | 1987-05-14 | 2000-07-04 | Glaxo Group Ltd | Beklede cefuroximaxetilsamenstelling. |
JPH0751579B2 (ja) | 1987-11-07 | 1995-06-05 | 日本新薬株式会社 | キノリンカルボン酸誘導体 |
JPH0228178A (ja) | 1988-04-23 | 1990-01-30 | Toyama Chem Co Ltd | 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法 |
MY105136A (en) | 1988-04-27 | 1994-08-30 | Daiichi Seiyaku Co | Optically active pyridonecarboxylic acid derivatives. |
JPH0645601B2 (ja) | 1988-07-20 | 1994-06-15 | 三共株式会社 | キノロンカルボン酸誘導体 |
JPH01258666A (ja) | 1988-08-18 | 1989-10-16 | Kyorin Pharmaceut Co Ltd | 新規置換キノリンカルボン酸 |
PL166381B1 (pl) | 1989-08-16 | 1995-05-31 | Pfizer | Sposób wytwarzania nowych podstawionych kwasów 7-azabicyklochinolonokarboksylowych PL PL PL PL |
DK0587744T3 (da) * | 1991-05-28 | 2003-10-20 | Mcneil Ppc Inc | Tygbar sammensætning til frigørelse af et lægemiddel |
FI101150B (fi) | 1991-09-09 | 1998-04-30 | Sankyo Co | Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi |
TW209865B (ja) | 1992-01-10 | 1993-07-21 | Bayer Ag | |
JP3265680B2 (ja) * | 1992-03-12 | 2002-03-11 | 大正製薬株式会社 | 経口製剤用組成物 |
KR100218700B1 (ko) * | 1992-03-12 | 1999-09-01 | 우에하라 아끼라 | 경구용조성물 |
EP0670716B1 (en) * | 1992-11-30 | 2003-03-26 | Kv Pharmaceutical Company | Tastemasked pharmaceutical materials |
WO1994014794A1 (en) | 1992-12-28 | 1994-07-07 | Yoshitomi Pharmaceutical Industries, Ltd. | 8-methoxyquinolonecarboxylic acid derivative |
US5527910A (en) | 1992-12-30 | 1996-06-18 | Cheil Foods & Chemicals, Inc. | Pyridone carboxylic acid compounds and their uses for treating infectious diseases caused by bacteria |
CN1041202C (zh) | 1993-08-13 | 1998-12-16 | 同和药品工业株式会社 | 一种具有药物活性的喹诺酮羧酸衍生物 |
TW252107B (ja) | 1993-08-27 | 1995-07-21 | Hokuriku Pharmacetical Co Ltd | |
JPH07242568A (ja) | 1994-03-04 | 1995-09-19 | Eisai Co Ltd | 苦味隠蔽製剤 |
JPH07267850A (ja) | 1994-03-28 | 1995-10-17 | Eisai Co Ltd | 不快味を防止した医薬組成物及びその製造方法 |
JPH07285838A (ja) * | 1994-04-15 | 1995-10-31 | Lion Corp | 口腔用組成物 |
EP0688772B1 (en) | 1994-06-16 | 1999-05-06 | LG Chemical Limited | Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituents and processes for their preparation |
US5972373A (en) * | 1995-05-02 | 1999-10-26 | Taisho Pharmaceutical Co., Ltd. | Taste masking pharmaceutical composition for oral administration |
US5602254A (en) | 1995-05-26 | 1997-02-11 | Warner-Lambert Company | Method for making quinoline carboxylic acids or naphthyridine carboxylic acids in free base form |
IL122296A0 (en) | 1995-06-06 | 1998-04-05 | Abbott Lab | Quinolizinone type compounds |
EA000467B1 (ru) * | 1995-07-21 | 1999-08-26 | Дайити Фармасьютикал Ко., Лтд. | Гранулированный препарат и способ его получения |
IT1276160B1 (it) * | 1995-11-22 | 1997-10-27 | Recordati Chem Pharm | Composizioni farmaceutiche orali a pronto rilascio per sospensioni estemporanee |
ES2258780T3 (es) | 1995-11-22 | 2006-09-01 | Daiichi Pharmaceutical Co., Ltd. | Derivados de aminocicloalquilpirrolidina sustituidos. |
CA2242242C (en) | 1996-02-09 | 2001-08-07 | Toyama Chemical Co., Ltd. | Quinolonecarboxylic acid derivatives or salts thereof |
ID16655A (id) | 1996-04-24 | 1997-10-30 | Daiichi Seiyaku Co | Turunan-turunan sikloalkilaminometilpirolidina |
WO1998002431A1 (en) | 1996-07-12 | 1998-01-22 | Daiichi Pharmaceutical Co., Ltd. | cis-SUBSTITUTED AMINOCYCLOPROPANE DERIVATIVES |
TW519542B (en) | 1996-09-27 | 2003-02-01 | Daiichi Seiyaku Co | Bicyclic amine derivative |
PT947513E (pt) | 1996-10-25 | 2004-09-30 | Daiichi Seiyaku Co | Derivados de amina triciclicos |
AU1040597A (en) | 1996-12-04 | 1998-06-29 | Daiichi Pharmaceutical Co., Ltd. | Substituted aminomethylpyrrolidine derivatives |
IL132982A0 (en) | 1997-05-21 | 2001-03-19 | Daiichi Seiyaku Co | Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives |
MY119816A (en) | 1997-05-30 | 2005-07-29 | Daiichi Seiyaku Co | Substituted cyclobutylamine derivatives |
KR20010014209A (ko) | 1997-06-24 | 2001-02-26 | 스즈키 다다시 | 시스-치환된 플루오로메틸피롤리딘 유도체 |
JPH1135486A (ja) * | 1997-07-23 | 1999-02-09 | Lion Corp | 薬用固形製剤 |
US6432442B1 (en) * | 1998-02-23 | 2002-08-13 | Mcneil-Ppc, Inc. | Chewable product |
-
2000
- 2000-03-16 KR KR1020017011627A patent/KR100768034B1/ko not_active IP Right Cessation
- 2000-03-16 CA CA2367373A patent/CA2367373C/en not_active Expired - Fee Related
- 2000-03-16 CN CN008050538A patent/CN1343128B/zh not_active Expired - Fee Related
- 2000-03-16 AU AU31927/00A patent/AU3192700A/en not_active Abandoned
- 2000-03-16 EP EP10010622A patent/EP2275141A1/en not_active Withdrawn
- 2000-03-16 EP EP00909677A patent/EP1161956A4/en not_active Withdrawn
- 2000-03-16 WO PCT/JP2000/001606 patent/WO2000054811A1/ja not_active Application Discontinuation
- 2000-03-16 RU RU2001128071/15A patent/RU2270695C2/ru not_active IP Right Cessation
- 2000-03-16 JP JP2000073572A patent/JP4694669B2/ja not_active Expired - Lifetime
- 2000-03-17 TW TW089104960A patent/TWI251495B/zh not_active IP Right Cessation
-
2001
- 2001-09-14 NO NO20014490A patent/NO20014490L/no not_active Application Discontinuation
-
2002
- 2002-08-22 HK HK02106154.7A patent/HK1044476B/zh not_active IP Right Cessation
-
2004
- 2004-10-07 US US10/959,297 patent/US20050152975A1/en not_active Abandoned
-
2006
- 2006-12-01 US US11/565,733 patent/US20070148235A1/en not_active Abandoned
-
2010
- 2010-10-08 JP JP2010228566A patent/JP2011006481A/ja active Pending
-
2011
- 2011-01-06 US US12/985,476 patent/US20110159049A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO20014490L (no) | 2001-11-14 |
NO20014490D0 (no) | 2001-09-14 |
CN1343128A (zh) | 2002-04-03 |
KR20010102571A (ko) | 2001-11-15 |
EP1161956A1 (en) | 2001-12-12 |
CN1343128B (zh) | 2010-04-21 |
JP4694669B2 (ja) | 2011-06-08 |
CA2367373C (en) | 2011-09-20 |
RU2270695C2 (ru) | 2006-02-27 |
HK1044476B (zh) | 2010-09-17 |
EP2275141A1 (en) | 2011-01-19 |
JP2000327590A (ja) | 2000-11-28 |
TWI251495B (en) | 2006-03-21 |
HK1044476A1 (en) | 2002-10-25 |
US20070148235A1 (en) | 2007-06-28 |
CA2367373A1 (en) | 2000-09-21 |
KR100768034B1 (ko) | 2007-10-17 |
WO2000054811A1 (fr) | 2000-09-21 |
US20050152975A1 (en) | 2005-07-14 |
US20110159049A1 (en) | 2011-06-30 |
JP2011006481A (ja) | 2011-01-13 |
EP1161956A4 (en) | 2005-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3192700A (en) | Medicinal compositions | |
AU781269C (en) | Pharmaceutical compositions | |
AU2115301A (en) | Dental compositions | |
AU2001250420A1 (en) | Pharmaceutical compositions | |
AU2001274307A1 (en) | Pharmaceutical compositions | |
GB0028088D0 (en) | Pharmaceutical compositions | |
GB0001662D0 (en) | Pharmaceutical compositions | |
AU2005300A (en) | Medicinal compositions | |
AU3556400A (en) | Pharmaceutical compositions | |
AU1887401A (en) | Medicinal composition | |
AU2002214324A1 (en) | Medicinal compositions | |
AU4428000A (en) | Pulse-delivery oral compositions | |
AU6715600A (en) | Pharmaceutical formulations | |
AU2001290239A1 (en) | Medicinal composition | |
GB9904163D0 (en) | Pharmaceutical compositions | |
AU4304400A (en) | Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives | |
AU6460400A (en) | Pharmaceutical compositions | |
AU2001273919A1 (en) | Pharmaceutical compositions | |
AU2681500A (en) | Rapidly-soluble compositions | |
GB9911017D0 (en) | Pharmaceutical compositions | |
AU4977300A (en) | Pharmaceutical formulations | |
AU6460200A (en) | Pharmaceutical compositions | |
AU1385801A (en) | Pharmaceutical formulations | |
AU5085300A (en) | Compositions | |
AU4085201A (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |